Sh2b3−/− mice exhibit features of myeloproliferative neoplasms (MPNs) such as splenomegaly and extramedullary hematopoiesis, and inactivatingSH2B3 mutations are associated with myeloproliferative disease in humans115. Here, SH2B3 is linked to myeloproliferative disorder.